88 related articles for article (PubMed ID: 25042198)
1. Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts.
Logan R; Kong AC; Krise JP
J Pharm Sci; 2014 Oct; 103(10):3287-96. PubMed ID: 25042198
[TBL] [Abstract][Full Text] [Related]
2. Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study.
Logan R; Kong AC; Axcell E; Krise JP
J Pharm Sci; 2014 May; 103(5):1572-80. PubMed ID: 24647827
[TBL] [Abstract][Full Text] [Related]
3. Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.
Funk RS; Krise JP
Mol Pharm; 2012 May; 9(5):1384-95. PubMed ID: 22449202
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes.
Logan R; Kong A; Krise JP
J Pharm Sci; 2013 Nov; 102(11):4173-80. PubMed ID: 23970383
[TBL] [Abstract][Full Text] [Related]
5. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
Logan R; Funk RS; Axcell E; Krise JP
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):943-58. PubMed ID: 22616667
[TBL] [Abstract][Full Text] [Related]
6. Identification of lysosomotropic compounds based on the distribution and size of lysosomes.
Seo I; Jha BK; Lim JG; Suh SI; Suh MH; Baek WK
Biochem Biophys Res Commun; 2014 Jul; 450(1):189-94. PubMed ID: 24878535
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications.
Kaufmann AM; Krise JP
J Pharm Sci; 2007 Apr; 96(4):729-46. PubMed ID: 17117426
[TBL] [Abstract][Full Text] [Related]
8. Lysosomal Biogenesis and Implications for Hydroxychloroquine Disposition.
Collins KP; Witta S; Coy JW; Pang Y; Gustafson DL
J Pharmacol Exp Ther; 2021 Feb; 376(2):294-305. PubMed ID: 33172973
[TBL] [Abstract][Full Text] [Related]
9. Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis.
Zhitomirsky B; Assaraf YG
Oncotarget; 2017 Jul; 8(28):45117-45132. PubMed ID: 28187461
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of amine accumulation in, and egress from, lysosomes.
Goldman SD; Funk RS; Rajewski RA; Krise JP
Bioanalysis; 2009 Nov; 1(8):1445-59. PubMed ID: 21083094
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
Kazmi F; Hensley T; Pope C; Funk RS; Loewen GJ; Buckley DB; Parkinson A
Drug Metab Dispos; 2013 Apr; 41(4):897-905. PubMed ID: 23378628
[TBL] [Abstract][Full Text] [Related]
12. Evidence for lysosomotropic action of desipramine in cultured human fibroblasts.
Honegger UE; Roscher AA; Wiesmann UN
J Pharmacol Exp Ther; 1983 May; 225(2):436-41. PubMed ID: 6221090
[TBL] [Abstract][Full Text] [Related]
13. Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99.
Lemieux B; Percival MD; Falgueyret JP
Anal Biochem; 2004 Apr; 327(2):247-51. PubMed ID: 15051542
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal biogenesis in lysosomal storage disorders.
Karageorgos LE; Isaac EL; Brooks DA; Ravenscroft EM; Davey R; Hopwood JJ; Meikle PJ
Exp Cell Res; 1997 Jul; 234(1):85-97. PubMed ID: 9223373
[TBL] [Abstract][Full Text] [Related]
15. Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro.
Ndolo RA; Luan Y; Duan S; Forrest ML; Krise JP
PLoS One; 2012; 7(11):e49366. PubMed ID: 23145164
[TBL] [Abstract][Full Text] [Related]
16. Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice.
Tanaka Y; Matsuwaki T; Yamanouchi K; Nishihara M
Neuroscience; 2013 Oct; 250():8-19. PubMed ID: 23830905
[TBL] [Abstract][Full Text] [Related]
17. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
[TBL] [Abstract][Full Text] [Related]
18. Influence of lipophilicity and lysosomal accumulation on tissue distribution kinetics of basic drugs: a physiologically based pharmacokinetic model.
Yokogawa K; Ishizaki J; Ohkuma S; Miyamoto K
Methods Find Exp Clin Pharmacol; 2002 Mar; 24(2):81-93. PubMed ID: 12040887
[TBL] [Abstract][Full Text] [Related]
19. Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system.
Kornhuber J; Henkel AW; Groemer TW; Städtler S; Welzel O; Tripal P; Rotter A; Bleich S; Trapp S
J Cell Physiol; 2010 Jul; 224(1):152-64. PubMed ID: 20301195
[TBL] [Abstract][Full Text] [Related]
20. Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease.
Fuller M; Rozaklis T; Lovejoy M; Zarrinkalam K; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2008 Apr; 93(4):437-43. PubMed ID: 18162427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
